Transplant vs bortezomib and LEN/DEX in multiple myeloma

Rafael Fonseca, MD from the Mayo Clinic, Scottsdale, AZ provides an overview of a clinical trial (IFM 2013-04) of bortezomib plus lenalidomide and dexamethasone (LEN/DEX) as the primary treatment for ... Author: VJHemOnc Added: 02/10/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts